Series B · $2.1B
$2.1B Series B.
Vertical + Enterprise · Private company · Growth
Isomorphic Labs
✓ VerifiedIsomorphic Labs matters because it represents one of the strongest attempts to turn frontier AI research into a drug-discovery company with real pharma leverage.
London, UKFounded 2021No public API trackedWeekday review
Editorial intelligence brief
What matters now
Isomorphic Labs continues building AI drug design programs and pharmaceutical partnerships around its AlphaFold-derived research stack.
Focus: AI-first drug discovery built on frontier biology and model-driven design
Latest funding
$2.1B
Series B · source-backed
Tracked funding
$2.1B
Sum of itemized funding events
Latest valuation
Not tracked
No source-backed record
Latest revenue
Not tracked
Growth lifecycle position
Source-backed financial history
Capital and commercial trajectory
Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.
Records
1
Tracked total
$2.1B
Coverage
partial
#1
Series B · $2.1B
Running tracked total: $2.1B
Every numbered chart marker maps to one source-linked funding announcement below.
Isomorphic Labs ↗ source for Series B $2.1B
Chronological activity
What changed
Isomorphic Labs continues building AI drug design programs and pharmaceutical partnerships around its AlphaFold-derived research stack.
A structured event record is still being assembled for this company.
Recent coverage of Isomorphic Labs
Consolidated by storyProduct surface
Products and model families
Recent models
No standalone model family is structured for this profile.
Products
AI drug design platform
Open weights
No
API access
No
Review cadence
Weekdays
Market position
Lifecycle and strategic signals
Research
Preview
Growth
Deployment
Growth: Public access & scaling
Focus
AI-first drug discovery built on frontier biology and model-driven design
Signals
ScienceBiotechScientific discovery
Taxonomy
Frontier LabsBiotechai-for-scienceResearch
Competitive context
Insilico MedicineRecursionGenerate:Biomedicines
Infrastructure & distribution
Where Isomorphic Labs sits in the AI stack
01
Model layer
No standalone model family tracked
02
Access layer
Application or managed product
03
Market layer
Vertical + Enterprise
Public product surface
AI drug design platform
Stack signals
Biotechai-for-scienceResearchScienceScientific discovery
This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.
Evidence trail
Sources and corrections
Primary and public sources used to verify the structured company profile.
The Staticbreaker
Get the signal behind the week's AI changes.
The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.